RELAY THERAPEUTICS INC
RLAYNASDAQ🏆 #1223 by market capEarnings Nov 5US Equity
$19.99▲ $0.05 (+0.25%)
Market closed · at close1h—
24h▲ 0.3%
7d▲ 1.5%
14d▲ 8.9%
30d▲ 6.7%
1y▲ 495.8%
🏦Market Cap
$4.31B
Small Cap
📈Revenue Growth (YoY)
+23.9%
Healthy
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
422.2x
Expensive
Otter Score
46
Weak
📊
Analyst Ratings
Price
$19.99
Total
15
Raised
1
Lowered
0
Avg PT
$26.13
H / L
$31 / $18
| Institution | Action | Rating | Date |
|---|---|---|---|
Goldman Sachs | Reiterated | Buy | 2026-07-21 |
Guggenheim | Reiterated | Buy | 2026-05-26 |
HC Wainwright & Co. | Reiterated | Buy | 2026-05-26 |
Barclays | Reiterated | Overweight | 2026-05-20 |
Citizens | Reiterated | Market Outperform | 2026-05-20 |
Raymond James | Reiterated | Strong Buy | 2026-05-19 |
Oppenheimer | Reiterated | Outperform | 2026-04-28 |
Wells Fargo | Reiterated | Overweight | 2026-04-28 |
Stifel | Reiterated | Buy | 2025-02-27 |
JMP Securities | Reiterated | Market Outperform | 2024-12-12 |
Leerink Partners | Reiterated | Outperform | 2024-12-05 |
JP Morgan | Reiterated | Overweight | 2024-09-10 |
Jefferies | Upgraded | Hold → Buy | 2024-09-10 |
B of A Securities | Reiterated | Buy | 2024-09-10 |
Berenberg | Reiterated | Buy | 2022-02-01 |
One row per institution, most recent rating